Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Nilsson, , Khalid,
DOB: 10-APR-1952 (Age: 73)
Gender: male
Address:
Gengränd 482
691 31 Karlskoga (Sweden)
ID: 8339-594203-6 (ECI)
Report
Date: 20-SEP-2022
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Karlskoga Lasarett
691 31 Karlskoga (Sweden)
Specimen
Collected: 19-SEP-2022

Chemistry

Test 20-SEP-2022 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.2 4.5 - 6.4 %
Glucose [Mass/volume] in Blood 97.9 70 - 99 mg/dL
Urea nitrogen [Mass/volume] in Blood 10.8 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.8 L 0.9 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.4 8.6 - 10.2 mg/dL
Sodium [Moles/volume] in Blood 141.3 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.7 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 102.0 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 28.4 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 144.8 0 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 122.9 40 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 80.1 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 40.2 40 - 100 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
All measured parameters are within or close to normal ranges. HbA1c is at the upper limit, suggesting good but borderline glycemic control. Creatinine is slightly below normal but not clinically significant. Lipid profile is favorable, with LDL and triglycerides well controlled and HDL at the lower normal limit. No acute abnormalities detected. Recommend continued monitoring, especially of glycemic control.